4D Pharma Plc ADR (LBPS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 05-2019 | 02-2019 | 12-2018 | 11-2018 | 08-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 10 | N/A | -20 | -23 | -7 |
| Other Working Capital | 42 | N/A | -60 | -68 | -26 |
| Other Operating Activity | -252 | 0 | -210 | -201 | 0 |
| Operating Cash Flow | $-201 | $N/A | $-290 | $-292 | $-33 |
| Cash Flows From Investing Activities | |||||
| Purchase Of Investment | N/A | N/A | N/A | -40,000 | -40,000 |
| Other Investing Activity | 0 | 0 | -40,000 | 0 | 0 |
| Investing Cash Flow | $N/A | $N/A | $-40,000 | $-40,000 | $-40,000 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 202 | 202 |
| Debt Repayment | N/A | N/A | N/A | -202 | -202 |
| Common Stock Issued | N/A | N/A | N/A | 41,525 | 41,525 |
| Other Financing Activity | 0 | 0 | 41,090 | -431 | -431 |
| Financing Cash Flow | $N/A | $N/A | $41,090 | $41,094 | $41,094 |
| Beginning Cash Position | 639 | N/A | N/A | 0 | 0 |
| End Cash Position | 439 | N/A | 800 | 802 | 1,061 |
| Net Cash Flow | $-201 | $N/A | $800 | $802 | $1,061 |
| Free Cash Flow | |||||
| Operating Cash Flow | -201 | N/A | -290 | -292 | -33 |
| Free Cash Flow | -201 | 0 | -290 | -292 | -33 |